201 related articles for article (PubMed ID: 35959146)
1. Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant
Meng H; Han L; Niu M; Xu L; Xu M; An Q; Lu J
Infect Drug Resist; 2022; 15():4241-4251. PubMed ID: 35959146
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream Infections due to Carbapenem-Resistant
Shen L; Lian C; Zhu B; Yao Y; Yang Q; Zhou J; Zhou H
Microb Drug Resist; 2021 Feb; 27(2):227-233. PubMed ID: 32584202
[TBL] [Abstract][Full Text] [Related]
3. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors of 30-Day All-Cause Mortality in Patients with Carbapenem-Resistant
Liu KS; Tong YS; Lee MT; Lin HY; Lu MC
J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34209780
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study.
Meng H; Yang J; Niu M; Zhu H; Zhou Y; Lu J
Int J Antimicrob Agents; 2023 Oct; 62(4):106933. PubMed ID: 37500022
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
Chang H; Wei J; Zhou W; Yan X; Cao X; Zuo L; Chen S; Yao K; Huang R; Chen Y; Wu C
J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
[TBL] [Abstract][Full Text] [Related]
7. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Falcone M; Bassetti M; Tiseo G; Giordano C; Nencini E; Russo A; Graziano E; Tagliaferri E; Leonildi A; Barnini S; Farcomeni A; Menichetti F
Crit Care; 2020 Jan; 24(1):29. PubMed ID: 32000834
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant
Zhang P; Wang J; Hu H; Zhang S; Wei J; Yang Q; Qu T
Infect Drug Resist; 2020; 13():3233-3242. PubMed ID: 33061470
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of
Tian L; Tan R; Chen Y; Sun J; Liu J; Qu H; Wang X
Antimicrob Resist Infect Control; 2016; 5():48. PubMed ID: 27891222
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P
Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: Clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing.
Zhang G; Zhang M; Sun F; Zhou J; Wang Y; Zhu D; Chen Z; Chen Q; Chang Q; Liu H; Chai W; Pan H
J Infect Public Health; 2020 Nov; 13(11):1710-1714. PubMed ID: 33082112
[TBL] [Abstract][Full Text] [Related]
12. Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant
Sun X; Zou X; Zhou B; Yin T; Wang P
Front Med (Lausanne); 2023; 10():1230721. PubMed ID: 37795412
[TBL] [Abstract][Full Text] [Related]
13. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.
Trecarichi EM; Pagano L; Martino B; Candoni A; Di Blasi R; Nadali G; Fianchi L; Delia M; Sica S; Perriello V; Busca A; Aversa F; Fanci R; Melillo L; Lessi F; Del Principe MI; Cattaneo C; Tumbarello M;
Am J Hematol; 2016 Nov; 91(11):1076-1081. PubMed ID: 27428072
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y
J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799
[TBL] [Abstract][Full Text] [Related]
15. Ceftazidime/Avibactam, Polymyxin or Tigecycline as a Rescue Strategy for the Treatment of Carbapenem-Resistant
Fang Y; Zhong Q; Chen Y; Hang Y; Fang X; Xiao Y; Cao X; Zhu H; Luo H; Peng S; Gu S; Li F; Zhu J; Xiong J; Hu L
Infect Drug Resist; 2023; 16():2963-2971. PubMed ID: 37201125
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant
Zheng X; Wang JF; Xu WL; Xu J; Hu J
Antimicrob Resist Infect Control; 2017; 6():102. PubMed ID: 29026535
[TBL] [Abstract][Full Text] [Related]
17. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
[TBL] [Abstract][Full Text] [Related]
18. Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant
Zhen S; Zhao Y; Chen Z; Zhang T; Wang J; Jiang E; Zhang F; Mi Y; Zhu X; Han M; Xiao Z; Wang J; Feng S
Front Cell Infect Microbiol; 2023; 13():1156651. PubMed ID: 37415825
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Prognosis of Bloodstream Infection with Carbapenem-Resistant
Yuan F; Xiao W; Wang X; Fu Y; Wei X
Infect Drug Resist; 2023; 16():4943-4952. PubMed ID: 37546370
[TBL] [Abstract][Full Text] [Related]
20. A Novel Nomogram for Predicting Risk Factors and Outcomes in Bloodstream Infections Caused by
Chen Y; Ying S; Jiang L; Dong S; Dai J; Jin X; Yu W; Qiu Y
Infect Drug Resist; 2022; 15():1317-1328. PubMed ID: 35378894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
